PROVECTUS BIOPHARMACEUTICALS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROVECTUS BIOPHARMACEUTICALS *W EXP 06/19/202, CUSIP 74373P116.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROVECTUS BIOPHARMACEUTICALS *W EXP 06/19/202, CUSIP 74373P116.